Thomas Nowack
YOU?
Author Swipe
DanGer Shock‐like profile predicts the outcome in ST‐elevation myocardial infarction‐related cardiogenic shock Open
Aims The DanGer Shock (DGS) trial demonstrated that the routine use of a microaxial flow pump (mAFP) with standard care to treat STEMI‐related cardiogenic shock (STEMI‐CS) led to a lower risk of all‐cause death at 180 days than standard ca…
View article: Sex-Related Differences in Outcome of Patients Treated With Microaxial Percutaneous Left Ventricular Assist Device for Cardiogenic Shock
Sex-Related Differences in Outcome of Patients Treated With Microaxial Percutaneous Left Ventricular Assist Device for Cardiogenic Shock Open
This study showed no differences in all-cause mortality at 30 days between male and female patients receiving microaxial pLVAD in CS. Larger studies are required to confirm whether female sex is associated with reduced requirement of RRT i…
View article: Novel scoring system specific for patients treated with micro-axial percutaneous left ventricular assist device
Novel scoring system specific for patients treated with micro-axial percutaneous left ventricular assist device Open
Background Cardiogenic shock (CS) is characterized by high mortality. The impact of micro-axial percutaneous left ventricular assist devices (ma-pLVAD) remains unclear. Nevertheless, the utilization of these devices increased lately which …
View article: Accuracy of different scoring systems in cardiogenic shock patients treated with micro-axial percutaneous left ventricular assist device
Accuracy of different scoring systems in cardiogenic shock patients treated with micro-axial percutaneous left ventricular assist device Open
Background Cardiogenic shock (CS) is the most severe form of acute heart failure characterized by high mortality. Micro-axial percutaneous left ventricular assist devices (pLVAD) might improve outcome. The utilization of these devices incr…
View article: Single-Site Experience with an Automated Artificial Intelligence Application for Left Ventricular Ejection Fraction Measurement in Echocardiography
Single-Site Experience with an Automated Artificial Intelligence Application for Left Ventricular Ejection Fraction Measurement in Echocardiography Open
Left ventricular ejection fraction (LVEF) is a key parameter in evaluating left ventricular (LV) function using echocardiography (Echo), but its manual measurement by the modified biplane Simpson (MBS) method is time consuming and operator…
View article: Left ventricular ejection fraction – human vs artificial intelligence: quo vadis?
Left ventricular ejection fraction – human vs artificial intelligence: quo vadis? Open
Background/Introduction Two-dimensional echocardiography (Echo) is a feasible method for assessing left ventricular (LV) ejection fraction (EF) in daily practice. However, the interpretation of Echo exams depends on the user's expertise an…
View article: Gender differences with the use of percutaneous left ventricular assist device in cardiogenic shock patients – results from the Dresden Impella Registry
Gender differences with the use of percutaneous left ventricular assist device in cardiogenic shock patients – results from the Dresden Impella Registry Open
Background Cardiogenic shock (CS) is a state of end-organ hypoperfusion due to cardiac output failure and is characterized by high mortality. Percutaneous left ventricular assist devices (pLVAD), like the Impella® system, support the left …
Predictive value of the APACHE II score in cardiogenic shock patients treated with a percutaneous left ventricular assist device Open
The APACHE II score has an acceptable accuracy for the prediction of intrahospital mortality but overestimates its total amount in CS patients. Adjustment of the DCW can lead to a much more precise prediction of prognosis.